Frequently Asked Questions
What is the 52-week range for ILMN?
The 52-week high is $280.165 and the 52-week low is $88.
What is the P/E ratio for ILMN?
The Price to Earnings (P/E) ratio is 49.40.
What is the dividend yield for ILMN?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is 31.08%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is 18.36%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 7.55.
Analyst Recommendation Trends
Wall Street analyst consensus for ILMN over the last few months:
Latest ILMN News
Guggenheim Maintains Buy on Illumina, Raises Price Target to $305
Guggenheim analyst Subbu Nambi maintains Illumina (NASDAQ:ILMN) with a Buy and raises the price target from $226 to $305.
Biomarkers Market Forecasts Growth from $67.95B (2026) to $112.10B by 2031, Profiling Roche, Abbott, Thermo Fisher & Qiagen
The global biomarkers market is projected to grow from USD 67.95 billion in 2026 to USD 112.10 billion by 2031, registering a 10.5% CAGR. Growth is driven by precision medicine, companion diagnostics, AI, bioinformatics, digital pathology and multi-omics technologies. Predictive biomarkers led the efficacy segment in 2025, while immunoassays held the largest technology share. Asia Pacific is forecast to be the fastest-growing region. Key players include Roche, Abbott, Thermo Fisher Scientific, Q
The Top HealthTech Questions Landing On Our Desks
Strong performance across the healthtech sector over the past two quarters has sparked renewed market interest in medical innovation.
Why Is PacBio (PACB) Stock Soaring Today
Shares of genomics company Pacific Biosciences of California (NASDAQ:PACB) jumped 29.7% in the afternoon session after EpiSign announced the launch of EpiSign METRIC 5-base, enabling laboratories to analyze DNA methylation data on the company's HiFi sequencing platform.
3 Reasons to Buy Grail (GRAL) Hand Over Fist in October
The cancer blood test maker could have a bright future.
3 Reasons to Sell ILMN and 1 Stock to Buy Instead
What a fantastic six months it’s been for Illumina. Shares of the company have skyrocketed 126%, hitting $273.47. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
REGN or ILMN: Which Is the Better Value Stock Right Now?
REGN vs. ILMN: Which Stock Is the Better Value Option?
Leerink Partners Maintains Outperform on Illumina, Raises Price Target to $300
Leerink Partners analyst Puneet Souda maintains Illumina (NASDAQ:ILMN) with a Outperform and raises the price target from $220 to $300.
Is the Options Market Predicting a Spike in Illumina Stock?
Investors need to pay close attention to ILMN stock based on the movements in the options market lately.
Piper Sandler Maintains Overweight on Illumina, Raises Price Target to $305
Piper Sandler analyst David Westenberg maintains Illumina (NASDAQ:ILMN) with a Overweight and raises the price target from $225 to $305.
What Needs To Be True To Buy Twist Bioscience Stock Now?
A $10,000 holding in Twist Bioscience (TWST) a year ago is worth about $66,600 today. The same sum in the S&P 500 would be worth about $11,700. The company sells made-to-order DNA to drug makers and research labs. Its sales grow fast, but it still loses money. The price now counts on that growth lasting and the losses ending. How much has to go right for that price to hold.
Illumina Stock Popped 7% to a 52-Week High. Here’s Where the Stock Goes From Here
Key Stats for Illumina StockCurrent Price: $273. 90Target Price (Mid): ~$412Street Target: ~$203Potential Total Return: ~50%Annualized IRR: ~10% / yearWhat Happened?Illumina (ILMN) closed at $273.
Illumina (ILMN) Tests Valuation As Russell Index Removal Forces A Fresh Look
Index removal puts Illumina in focus Illumina (ILMN) has been removed from the Russell Small Cap Value Index, an index reshuffle that can prompt mechanical selling and raise fresh questions about how the stock is being valued today. The index removal comes at a time when Illumina’s momentum is already strong, with a 1-day share price return of 7.25%, a 30-day share price return of 21.82% and a year-to-date share price return of 103.87%. These feed into a 1-year total shareholder return of...
Illumina Stock Surges 94.9% YTD: What's Behind the Rally?
ILMN's 94.9% YTD rally reflects strong sequencing growth, clinical adoption and a raised 2026 outlook despite China headwinds.
Analysts Think 6 S&P 500 Stocks Are Grossly Overvalued
There's a joke on Wall Street that analysts never saw an S&P 500 stock they didn't like. Well, that doesn't seem to be the case now.
3 Healthcare Stocks with Warning Signs
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have returned 38.9% over the past six months, topping the S&P 500 by 20.9 percentage points.
Here's How Much $1000 Invested In Illumina 20 Years Ago Would Be Worth Today
Illumina (NASDAQ:ILMN) has outperformed the market over the past 20 years by 5.48% on an annualized basis producing an average annual return of 14.65%. Currently, Illumina has a market capitalization of $37.84 billion.
NICU Genetic Testing Market Size, Share & Trends Analysis - Global Opportunity Analysis and Industry Forecast (2026-2036)
The global NICU genetic testing market is forecast to grow from USD 1.74 billion in 2026 to USD 4.80 billion by 2036, at a 10.67% CAGR. Growth is driven by rising neonatal genetic disorders, rapid whole genome and exome sequencing, next-generation sequencing, chromosomal microarrays and personalized neonatal care. North America leads the market, while Asia-Pacific is expected to grow fastest. The report analyzes key trends, technologies, segments, regional opportunities and leading companies, in
Biotech ETFs to Buy as Cancer Drug Breakthroughs Accelerate
Biotech ETFs offer diversified exposure to oncology innovation as cancer funding surges and the global oncology drug market expands.
Illumina Stock Is Up 133% This Year. Here’s Where It Could Go Further.
Key TakeawaysYear-Long Surge: Illumina stock has climbed 133% over the past year, closing at $240 on September 18, 2026, up from roughly $103 twelve months earlier. Street Split: Illumina stock carries 7 buy ratings, 4 outperforms, 6 holds, 3 underperforms and 1 sell, and the $203 mean target now sits 15% below where shares trade, a reversal from a year ago when the target sat above the price.
Grail Analyst Sees Massive Market Potential with Valuation Headwinds
Grail "is a pure play," according to RBC Capital Markets. The company offers a tool for screening malignancies that lack standard protocols.
Genomics Market Outlook 2026-2035 - Featuring Profiles of Illumina, Thermo Fisher Scientific, and Qiagen
AI, Advanced Sequencing and Precision Medicine Drive Genomics Opportunities Across Diagnostics, Drug Development and Preventive CareDublin, Sept. 18, 2026 (GLOBE NEWSWIRE) -- "Genomics Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035" has been added to ResearchAndMarkets.com's offering. Global Genomics Market Forecast to Reach USD 188.7 Billion by 2035, Driven by Precision Healthcare and Sequencing Innovation The global genomics market was valued at USD 44.7 bi
Pharmacogenomics Market Outlook 2026-2035 - Featuring Profiles of Thermo Fisher Scientific, Illumina, and Qiagen
Pharmacogenomics Expands as Multi-Gene Testing, Bioinformatics and Precision Diagnostics Drive Clinical AdoptionDublin, Sept. 18, 2026 (GLOBE NEWSWIRE) -- "Pharmacogenomics Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035" has been added to ResearchAndMarkets.com's offering. Global Pharmacogenomics Market to Reach USD 15.4 Billion by 2035, Driven by Precision Medicine Adoption The global pharmacogenomics market was valued at USD 5.7 billion in 2025 and is proje
Illumina Reports Q2 2026 Results: Full Earnings Call Transcript
On Thursday, Illumina (NASDAQ:ILMN) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This content is powered by Benzinga APIs. For comprehensive financial data
Is Brookdale Senior Living (BKD) Outperforming Other Medical Stocks This Year?
Here is how Brookdale Senior Living (BKD) and Illumina (ILMN) have performed compared to their sector so far this year.
Three Stocks Are Joining the S&P 500. Will They Actually Improve VOO’s Returns?
Three new names are entering the S&P 500, swapping out brewers and homebuilders for fuel-cell technology and genomics, but whether that trade actually benefits VOO holders depends on a math problem most investors overlook.
LuxExperience, Alvotech, Twist Bioscience And Other Big Stocks Moving Higher On Wednesday
U.S. stocks mixed as Nasdaq rises; LuxExperience jumps 13.5% on strong sales, while Einride, Forgent, Cipher and others post gains.
US Stock Market Today: S&P 500 Futures Edge Higher As Bond Yield Jitters Linger
The Morning Bull - US Market Morning Update Wednesday, Sep, 16 2026 US stock futures are pointing slightly higher in early trade, with E-mini S&P 500 contracts up about 0.3% and tech heavy Nasdaq futures ahead roughly 0.4%. The big driver is the US 10 year government bond yield, which briefly touched 5.01% before easing to 4.96%. That is the highest level since 2007 and means borrowing costs for mortgages, credit cards, and companies remain expensive. At the same time, rising government bond...
10-Year Yield Tops 5%, Oil Storms Past $105: Stock Market Today
The 10-year Treasury yield broke 5% for the first time since 2007 as WTI surged past $105 on Saudi pipeline outages, pressuring stocks ahead of the Fed.
Intel Upgraded, CVS Health Downgraded: Updated Rankings on Top Blue-Chip Stocks
During these busy times, it pays to stay on top of the latest profit opportunities. And today’s blog post should be a great place to start. After taking a close look at the latest data on institutional buying pressure and each company’s fundamental health, I decided to revise my Stock Grader recommendations for 93 big blue chips. Chances are that you have at least one of these stocks in your portfolio, so you may want to give this list a skim and act accordingly. This Week’s Ratings Changes: Upg
This Copart Analyst Turns Bullish; Here Are Top 2 Upgrades For Friday
Analysts upgraded Copart, Orchestra BioMed, Illumina, Martin Marietta Materials and Waters, raising their price targets.
Transcriptome Sequencing Market - Global Forecast to 2035; Bulk RNA-Seq Maintains Its Technology Market Lead
The global transcriptome sequencing market is projected to reach $11.8 billion by 2035, growing at a 7.3% CAGR from 2025 to 2035. Growth is driven by falling sequencing costs, precision medicine, drug discovery, biomarker development, single-cell and spatial transcriptomics, long-read RNA sequencing, and AI-powered analytics. Consumables, bulk RNA-seq, drug discovery applications, and pharmaceutical and biotechnology companies led the market in 2025. North America held the largest regional share
This Meta Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
Analysts upgraded SFNC, OBIO, and more.
S&P Dow Jones Indices CEO on Index Restructuring
Catherine Clay, CEO of S&P Dow Jones Indices, discusses the upcoming S&P reconstitution and rebalance, noting that the process is fully transparent and routine. She says market participants already know which names are entering and leaving the index, including Bloom Energy, Illumina and Everpure joining the S&P this month, and have ample time to adjust portfolios accordingly. She speaks with Romaine Bostick & Tyler Kendall on "The Close."
Reasons to Retain Tandem Diabetes Stock in Your Portfolio Now
TNDM's expanding pump lineup and pay-as-you-go model support growth prospects, though macro and competitive pressures remain.
Dear Illumina Stock Fans, Mark Your Calendars for September 21
Illumina stock is joining the S&P 500 on Sept. 21. Here's why that matters, what's fueling growth, and what investors should watch next.
Abbott Receives FDA Nod for TactiFlex Duo: Stock to Gain?
FDA approval for TactiFlex Duo expands ABT's AFib ablation portfolio with dual PFA and RF energy options, supporting broader U.S. adoption.
Dear Everpure Stock Fans, Mark Your Calendars for September 21
Everpure stock is joining the S&P 500 on Sept. 21. Here's what's changing, why it matters, and what's driving Everpure's growth this year.
This Illumina Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday
Analysts upgraded Sagimet, Figure, Illumina, Martin Marietta and Waters, raising price targets and improving ratings.
Encoded Therapeutics Raises $275 Million in Series F Financing to Advance ETX101 Through Pivotal Development and Accelerate its Precision Genetic Medicines Neurology Pipeline
SOUTH SAN FRANCISCO, Calif., September 09, 2026--Encoded Therapeutics Raises $275 Million in Series F Financing to Advance Precision Genetic Medicines Neurology Pipeline
UBS Upgrades Illumina to Buy, Raises Price Target to $260
UBS analyst Doug Schenkel upgrades Illumina (NASDAQ:ILMN) from Neutral to Buy and raises the price target from $135 to $260.
3 Stocks Soon Joining the S&P 500
The S&P 500 is set for another shakeup, with Bloom Energy (BE), Everpure (P), and Illumina (ILMN) all joining in the next quarterly rebalancing near the end of September.
ILMN Stock Keeps Climbing. Should You Climb On?
A gene sequencing leader is on a powerful run fueled by real business quality, forcing investors to decide if the engine has more power than the price tag already reflects.
3 Promising Genomics Stocks in the Spotlight in 2026
Genomics is reshaping healthcare, with WGS, NEO and NTLA advancing diagnostics and precision medicine.
Multiomics Market Report Now Available — See Why Spatial Omics Is Set to Outgrow Single-Cell as the Field's Next Growth Driver
578-Page Report Forecasts Market Growth from $3.18B (2026) to $5.7B by 2031, Profiling 10x Genomics, Thermo Fisher, Illumina, Oxford Nanopore, Bruker, and 14 Other Key Players Multiomics Market Multiomics Market Dublin, Sept. 08, 2026 (GLOBE NEWSWIRE) -- The "Multiomics Market by Offerings, Method, Technology, Workflow, Application, Competition - Global Forecast to 2031" has been added to ResearchAndMarkets.com's offering. Global Multiomics Market to Reach USD 5.70 Billion by 2031, Driven by Pre
Bloom Energy Stock Rallies on News of S&P 500 Addition
Shares of Bloom Energy are surging on the news that the company is set to join the S&P 500.
Bloom Energy’s S&P 500 Entry Could Bring A New Wave Of Buyers, Says Clear Street — Projects 20% Upside In BE Stock
Bloom Energy is set to join the S&P 500 before trading begins on September 21.
Qualcomm, Amgen, Novartis, Corning, Boeing, and More Stocks That Explain Today’s Market
Amgen falls following Swiss drugmaker Novartis’ disappointing trial data. Novartis trades sharply lower.
The Zacks Analyst Blog Highlights FANUY, ABBNY, KYCCF, NVDA, ISRG, ILMN, NOVT, BOTZ, ROBO, ROBT and IBOT
BOTZ offers diversified exposure to a robotics boom fueled by AI, humanoid robots and industrial automation, as the sector rapidly evolves.
Is it Prudent to Retain Insulet Stock in Your Portfolio for Now?
PODD's Omnipod 5 adoption, product expansion and raised international growth outlook support its growth prospects despite competitive and cost pressures.
Bloom Energy Joins the S&P 500 as The Trade Desk Leaves
Illumina and Everpure also join the S&P 500 in the September rebalance
Bloom Energy Is Joining the S&P 500: Is the Stock Still a Buy After Its Massive Run?
Bloom Energy has secured a spot in the S&P 500 as part of its quarterly rebalancing.
Premarket movers: Energy stocks rise on Iran tensions, Eaton jumps on UBS upgrade
Investing.com -- U.S. stock futures fell early Tuesday, kicking off a shortened trading week as Wall Street monitored the U.S.-Iran conflict alongside rising trade tensions between Canada and the U.S. Futures tied to the Dow Jones Industrial Average fell 0.8% by 05:30 ET (09:30 GMT). S&P 500 futures fell 0.3% and Nasdaq-100 futures slipped 0.1%. U.S. markets were closed Monday for Labor Day.
Ribbon Bio Appoints Jay Therrien as Chief Business Officer
Cell-free DNA assembly pioneer, Ribbon Bio, has today announced the appointment of Jay Therrien as Chief Business Officer. Therrien joins Ribbon's executive leadership team where he will lead the company's commercial strategy and growth initiatives.
Illumina: Priced For Perfection It Hasn't Earned Yet
Illumina (ILMN) stock is up 64% post-GRAIL spin-off.
S&P 500 Adds 3 Surging Stocks in Major Shake-Up
Three market winners are about to gain a powerful catalyst
Illumina and Everpure to Join S&P 500 in September Rebalancing: What it Means for Investors
Illumina, Inc. (NASDAQ:ILMN) and Everpure, Inc. (NYSE:P) are set to join the S&P 500 as part of the index’s quarterly rebalancing, with the changes taking effect before the market opens on September 21. Both companies will replace Builders FirstSource and The Trade Desk. Both companies are moving up from the S&P MidCap 400. The change […]
Illumina (ILMN) Upgraded to Buy: What Does It Mean for the Stock?
Illumina (ILMN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Dow Jones Futures Fall With Iran, Apple, Inflation In Focus; Nvidia, Micron, Sandisk Flash Buy Signals
Dow Jones futures: The U.S. and Iran exchanged attacks. Nvidia, Micron, Sandisk are buys, but for how long? Apple, inflation data loom.
Dow Jones Futures: U.S., Iran Exchange Attacks; Nvidia, Micron, Sandisk Flash Buy Signals
Dow Jones futures: The U.S. and Iran exchanged attacks. Nvidia, Micron, Sandisk are buys, but for how long? Apple, inflation data loom.
Illumina (ILMN) Stock Looks Priced For Growth More Than Value
Illumina stock has delivered a very strong 1 year return, yet its valuation checks pull in different directions, with an intrinsic value estimate pointing to upside while market based multiples suggest the shares are not cheap. The result is a stock that has re-rated sharply without a clear consensus on whether the current price offers much room for error. Illumina has returned 120.6% over the past year, which puts extra focus on whether recent gains already reflect optimistic...
Could Illumina’s Novacyt Collaboration Framework Quietly Reshape Its Clinical Sequencing Narrative (ILMN)?
In September 2026, Novacyt S.A. announced it had entered into a five-year Master Collaboration Agreement with Illumina, creating a framework for separate project-based deals in product development and commercial collaboration. This structure gives Illumina a flexible way to tap Novacyt’s complementary expertise without committing upfront capital to specific programs, potentially broadening future genomic applications. We’ll now examine how this new Master Collaboration framework with...
BE, P, ILMN Join S&P 500; LNG Misses Out — Bloom Energy Stock Gains While Cheniere Energy Slips
S&P said on Friday that Bloom Energy, Everpure (P) and Illumina (ILMN) will join the S&P 500 index.
Bloom Energy, Illumina, and Everpure Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400, and S&P SmallCap 600
S&P Dow Jones Indices will make the following changes to the S&P 500, S&P 100, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, September 21, 2026, to coincide with the quarterly rebalance. The changes ensure that each index is more representative of its market capitalization range. The companies being removed from the S&P SmallCap 600 are no longer representative of the small-cap market space.
Dow Jones Futures: Nvidia, Micron, Sandisk Flash Buy Signals; Apple, Inflation Reports Ahead
The stock market fell this week before bouncing. Nvidia, Micron, Sandisk are new buys, but for how long? Apple, inflation data loom.
Bloom Energy, Illumina, Everpure Rise On S&P 500 Inclusion
AI energy play Bloom Energy will be added to the S&P 500 index on Sept. 21. Illumina and Everpure also will join. The three stocks rose.
Bloom Energy, Illumina, and Everpure set to join S&P 500 in quarterly rebalance
Investing.com -- Shares of Bloom Energy Corp., Illumina Inc., and Everpure Inc. rallied in extended trading Friday following news that all three companies will be added to the benchmark S&P 500 index. The reshuffling, announced by S&P Dow Jones Indices, forms part of a broader quarterly rebalance designed to ensure index constituents remain representative of their respective market capitalization tiers. Bloom Energy led the late-session advance, surging 7.5% after hours, while Illumina gained 2%
Bloom Energy and These 2 Stocks Are Joining the S&P 500
The is getting three new members this month, with Bloom Energy Everpure and Illumina joining the benchmark as part of its latest quarterly reshuffle. Bloom Energy, which makes fuel-cell systems that provide on-site electricity to businesses and data centers, will replace Molson Coors Beverage the brewer behind brands including Coors Light and Miller Lite. Illumina, a maker of DNA-sequencing and genomic-analysis technology, will replace Builders FirstSource which supplies building materials and manufactured components to the U.S. residential-construction industry.
Is it a Prudent Move to Retain ALC Stock in Your Portfolio Now?
Alcon's acquisitions, partnerships and new product launches support growth, but tariffs and intense competition remain key risks.
Are Robots the New Normal? Bet on these ETFs to Invest in the Future
Robotics is entering a new era as AI fuels humanoid adoption, with four ETFs offering diversified exposure to the sector's growth.
10x Genomics Rallies 84% in 3 Months: Is There More Upside Ahead?
TXG's 84% rally is backed by consumables growth, Atera demand and higher guidance, but weak instruments and valuation raise the bar.
Governments Are Encouraging Industrial Robotic Growth
Robotics ETFs (BOTZ, ROBO, ARKQ) offer early growth, but industrial robotics leads. Weigh QQQ/SPY vs. niche ETF risksâread before investing.
Why Moderna's Cancer Vaccine Matters To Investors
As legacy pharmaceutical models face structural challenges, targeting the underlying technology enablers of next-generation care offers a compelling approach for healthcare investors.
Argus Research Maintains Buy on Illumina, Raises Price Target to $235
Argus Research analyst Jasper Hellweg maintains Illumina (NASDAQ:ILMN) with a Buy and raises the price target from $180 to $235.
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-09-08 | Coletti Julie Ann | +5,307 | - | - |
| 2026-09-08 | Coletti Julie Ann | +5,307 | - | - |
| 2026-09-08 | Coletti Julie Ann | +14,214 | - | - |
| 2026-09-08 | Coletti Julie Ann | +4,549 | - | - |
| 2026-09-05 | Barnard Steven | -408 | $211.06 | $86,112 |
| 2026-09-04 | Meister Keith A. | -11,351 | $219.18 | $2,487,912 |
| 2026-09-04 | Meister Keith A. | -100,650 | $218.39 | $21,980,954 |
| 2026-09-04 | Meister Keith A. | -7,500 | $217.28 | $1,629,600 |
| 2026-09-03 | Meister Keith A. | -9,961 | $221.55 | $2,206,860 |
| 2026-09-03 | Meister Keith A. | -6,656 | $220.17 | $1,465,452 |
| 2026-09-03 | Meister Keith A. | -13,717 | $219.41 | $3,009,647 |
| 2026-09-03 | Meister Keith A. | -9,721 | $218.33 | $2,122,386 |
| 2026-09-03 | Meister Keith A. | -14,196 | $217.29 | $3,084,649 |
| 2026-09-03 | Meister Keith A. | -13,261 | $216.38 | $2,869,415 |
| 2026-09-03 | Meister Keith A. | -8,439 | $215.2 | $1,816,073 |
| 2026-09-02 | Meister Keith A. | -10,620 | $213.73 | $2,269,813 |
| 2026-09-02 | Meister Keith A. | -57,488 | $213.2 | $12,256,442 |
| 2026-08-27 | Meister Keith A. | -9,405 | $231.23 | $2,174,718 |
| 2026-08-27 | Meister Keith A. | -28,439 | $230.54 | $6,556,327 |
| 2026-08-27 | Meister Keith A. | -16,990 | $229.72 | $3,902,943 |
| 2026-08-27 | Meister Keith A. | -24,363 | $228.64 | $5,570,356 |
| 2026-08-27 | Meister Keith A. | -54,309 | $227.67 | $12,364,530 |
| 2026-08-27 | Meister Keith A. | -4,873 | $226.74 | $1,104,904 |
| 2026-08-26 | Meister Keith A. | -425 | $227.22 | $96,569 |
| 2026-08-26 | Meister Keith A. | -14,782 | $226.5 | $3,348,123 |
| 2026-08-26 | Meister Keith A. | -53,123 | $225.69 | $11,989,330 |
| 2026-08-26 | Meister Keith A. | -38,213 | $224.72 | $8,587,225 |
| 2026-08-25 | Meister Keith A. | -42 | $226.79 | $9,525 |
| 2026-08-25 | Meister Keith A. | -38,201 | $226.13 | $8,638,392 |
| 2026-08-25 | Meister Keith A. | -92,776 | $225.26 | $20,898,722 |
| 2026-08-21 | Meister Keith A. | -3,883 | $220.13 | $854,765 |
| 2026-08-21 | Meister Keith A. | -133,256 | $219.47 | $29,245,694 |
| 2026-08-21 | Meister Keith A. | -86,825 | $218.6 | $18,979,945 |
| 2026-08-21 | Meister Keith A. | -8,187 | $217.84 | $1,783,456 |
| 2026-08-21 | Meister Keith A. | -12,602 | $216.44 | $2,727,577 |
| 2026-08-21 | Meister Keith A. | -9,365 | $215.61 | $2,019,188 |
| 2026-08-21 | Meister Keith A. | -13,668 | $214.64 | $2,933,700 |
| 2026-08-21 | Meister Keith A. | -6,821 | $213.81 | $1,458,398 |
| 2026-08-21 | Meister Keith A. | -13,050 | $212.65 | $2,775,083 |
| 2026-08-21 | Meister Keith A. | -7,151 | $211.54 | $1,512,723 |
| 2026-08-21 | Meister Keith A. | -4,528 | $210.45 | $952,918 |
| 2026-08-20 | Meister Keith A. | -9,348 | $219.82 | $2,054,877 |
| 2026-08-20 | Meister Keith A. | -5,693 | $218.46 | $1,243,693 |
| 2026-08-20 | Meister Keith A. | -21,147 | $217.72 | $4,604,125 |
| 2026-08-20 | Meister Keith A. | -15,263 | $216.88 | $3,310,239 |
| 2026-08-20 | Meister Keith A. | -18,405 | $215.62 | $3,968,486 |
| 2026-08-20 | Meister Keith A. | -42,218 | $214.57 | $9,058,716 |
| 2026-08-20 | Meister Keith A. | -71,939 | $213.36 | $15,348,905 |
| 2026-08-20 | Meister Keith A. | -29,805 | $212.83 | $6,343,398 |
| 2026-08-20 | Meister Keith A. | -34,009 | $211.9 | $7,206,507 |
| 2026-08-20 | Meister Keith A. | -23,638 | $210.66 | $4,979,581 |
| 2026-08-20 | Meister Keith A. | -9,078 | $209.68 | $1,903,475 |
| 2026-08-20 | Meister Keith A. | -3,563 | $208.55 | $743,064 |
| 2026-08-20 | Meister Keith A. | -1,132 | $207.65 | $235,060 |
| 2026-08-19 | Meister Keith A. | -12,813 | $205 | $2,626,665 |
| 2026-08-19 | Meister Keith A. | -4,759 | $204.16 | $971,597 |
| 2026-08-19 | Meister Keith A. | -57,544 | $203.16 | $11,690,639 |
| 2026-08-19 | Meister Keith A. | -19,884 | $202.37 | $4,023,925 |
| 2026-08-18 | Wedel Christensen Jakob | -1,033 | $191.52 | $197,840 |
| 2026-08-05 | Sullivan Michael C | +5,254 | - | - |
| 2026-08-05 | Sullivan Michael C | +5,254 | - | - |
| 2026-08-05 | Sullivan Michael C | +4,503 | $199.87 | $900,015 |
| 2026-08-05 | Meister Keith A. | -2,450 | $203.28 | $498,036 |
| 2026-08-05 | Meister Keith A. | -11,372 | $201.8 | $2,294,870 |
| 2026-08-05 | Meister Keith A. | -30,398 | $201.37 | $6,121,245 |
| 2026-08-05 | Meister Keith A. | -118,753 | $199.87 | $23,735,162 |
| 2026-08-05 | Meister Keith A. | -68,047 | $198.97 | $13,539,312 |
| 2026-08-05 | Meister Keith A. | -52,249 | $198.18 | $10,354,707 |
| 2026-08-04 | Meister Keith A. | -67,988 | $203.09 | $13,807,683 |
| 2026-08-04 | Meister Keith A. | -48,186 | $202.43 | $9,754,292 |
| 2026-08-04 | Meister Keith A. | -67,725 | $201.44 | $13,642,524 |
| 2026-08-04 | Meister Keith A. | -37,242 | $200.65 | $7,472,607 |
| 2026-08-04 | Meister Keith A. | -35,160 | $199.51 | $7,014,772 |
| 2026-08-04 | Meister Keith A. | -166,501 | $198.24 | $33,007,158 |
| 2026-08-04 | Meister Keith A. | -27,854 | $197.48 | $5,500,608 |
| 2026-08-04 | Meister Keith A. | -7,202 | $196.74 | $1,416,921 |
| 2026-07-30 | Davies Scott M | -615 | $200 | $123,000 |
| 2026-06-30 | Meister Keith A. | +142 | $149.1868 | $21,185 |
| 2026-06-30 | Ullem Scott B. | +167 | $149.1868 | $24,914 |
| 2026-06-25 | Davies Scott M | -615 | $180 | $110,700 |
| 2026-06-16 | Skovronsky Daniel | +1,674 | $164.28 | $275,005 |
| 2026-06-05 | Leckman Patricia | -2 | $167.88 | $336 |
| 2026-06-05 | Leckman Patricia | -39 | $164.82 | $6,428 |
| 2026-06-05 | Leckman Patricia | -78 | $163.36 | $12,742 |
| 2026-06-05 | Leckman Patricia | -374 | $162.78 | $60,880 |
| 2026-06-05 | Leckman Patricia | -290 | $161.79 | $46,919 |
| 2026-06-02 | Leckman Patricia | -290 | $163.02 | $47,276 |
| 2026-06-02 | Leckman Patricia | -318 | $162 | $51,516 |
| 2026-06-02 | Leckman Patricia | -176 | $160.66 | $28,276 |
| 2026-06-01 | Meister Keith A. | -15,472 | $165.5 | $2,560,616 |
| 2026-06-01 | Meister Keith A. | -87,653 | $164.34 | $14,404,894 |
| 2026-06-01 | Meister Keith A. | -61,613 | $163.56 | $10,077,422 |
| 2026-06-01 | Meister Keith A. | -70,262 | $162.41 | $11,411,251 |
| 2026-05-29 | Davies Scott M | -615 | $160 | $98,400 |
| 2026-05-29 | Ericksen Scott D | -500 | $160 | $80,000 |
| 2026-05-29 | Meister Keith A. | -1,961 | $165.3 | $324,153 |
| 2026-05-29 | Meister Keith A. | -92,877 | $164.56 | $15,283,839 |
| 2026-05-29 | Meister Keith A. | -6,198 | $163.97 | $1,016,286 |
| 2026-05-29 | Meister Keith A. | -63,020 | $162.86 | $10,263,437 |
| 2026-05-29 | Meister Keith A. | -6,888 | $164.75 | $1,134,798 |
| 2026-05-29 | Meister Keith A. | -19,832 | $163.57 | $3,243,920 |
| 2026-05-29 | Meister Keith A. | -2,225 | $162.44 | $361,429 |
| 2026-05-29 | Meister Keith A. | -5,256 | $161.64 | $849,580 |
| 2026-05-29 | Meister Keith A. | -4,579 | $160.5 | $734,930 |
| 2026-05-29 | Meister Keith A. | -11,760 | $159.57 | $1,876,543 |
| 2026-05-28 | Ericksen Scott D | -1,500 | $150.1 | $225,150 |
| 2026-05-28 | Meister Keith A. | -24,562 | - | - |
| 2026-05-28 | Meister Keith A. | -110,424 | $147.5 | $16,287,540 |
| 2026-05-28 | Meister Keith A. | -71,986 | $157.38 | $11,329,157 |
| 2026-05-28 | Meister Keith A. | -37,590 | $156.5 | $5,882,835 |
| 2026-05-28 | Meister Keith A. | -24,562 | $156.4 | $3,841,497 |
| 2026-05-28 | Meister Keith A. | +24,562 | $102.82 | $2,525,465 |
| 2026-05-21 | KING DAVID P | +2,072 | $144.83 | $300,088 |
| 2026-05-21 | SIEGEL SUSAN E | +2,072 | $144.83 | $300,088 |
| 2026-05-21 | Ullem Scott B. | +2,072 | $144.83 | $300,088 |
| 2026-05-21 | SCHILLER PHILIP W | +2,072 | $144.83 | $300,088 |
| 2026-05-21 | RICHO ANNA | +2,072 | $144.83 | $300,088 |
| 2026-05-21 | Meister Keith A. | +2,072 | $144.83 | $300,088 |
| 2026-05-21 | Gottlieb Scott | +2,072 | $144.83 | $300,088 |
| 2026-05-21 | DORSA CAROLINE | +2,072 | $144.83 | $300,088 |
| 2026-05-20 | DORSA CAROLINE | -1,512 | $141.92 | $214,583 |
| 2026-05-14 | Meister Keith A. | -180 | $147.8 | $26,604 |
| 2026-05-14 | Meister Keith A. | -13,776 | $146.96 | $2,024,521 |
| 2026-05-14 | Meister Keith A. | -25,352 | $146.15 | $3,705,195 |
| 2026-05-14 | Meister Keith A. | -52,776 | $144.8 | $7,641,965 |
| 2026-05-14 | Meister Keith A. | -12,309 | $144.13 | $1,774,096 |
| 2026-05-13 | Meister Keith A. | -5,310 | $148.14 | $786,623 |
| 2026-05-13 | Meister Keith A. | -6,524 | $147.5 | $962,290 |
| 2026-05-13 | Meister Keith A. | -53,610 | $145.94 | $7,823,843 |
| 2026-05-13 | Meister Keith A. | -159,623 | $145.26 | $23,186,837 |
| 2026-05-12 | Meister Keith A. | -255,378 | - | - |
| 2026-05-12 | Meister Keith A. | -255,378 | $144.66 | $36,942,981 |
| 2026-05-12 | Meister Keith A. | +255,378 | $102.82 | $26,257,966 |
| 2026-05-11 | Meister Keith A. | -79,568 | - | - |
| 2026-05-11 | Meister Keith A. | -79,568 | $143.45 | $11,414,030 |
| 2026-05-11 | Meister Keith A. | +79,568 | $102.82 | $8,181,182 |
| 2026-05-07 | Meister Keith A. | -9,236 | - | - |
| 2026-05-07 | Meister Keith A. | -9,236 | $140.25 | $1,295,349 |
| 2026-05-07 | Meister Keith A. | +9,236 | $102.82 | $949,646 |
| 2026-05-06 | Wedel Christensen Jakob | -700 | $139.04 | $97,328 |
| 2026-05-05 | Wedel Christensen Jakob | -233 | $139.07 | $32,403 |
| 2026-03-31 | Ullem Scott B. | +190 | $131.5473 | $24,994 |
| 2026-03-31 | Meister Keith A. | +161 | $131.5473 | $21,179 |
| 2026-03-05 | Barnard Steven | +8,871 | $128.74 | $1,142,053 |
| 2026-03-05 | Barnard Steven | +8,871 | $128.24 | $1,137,617 |
| 2026-03-05 | Barnard Steven | +7,603 | $128.24 | $975,009 |
| 2026-03-05 | Davies Scott M | +6,824 | $128.24 | $875,110 |
| 2026-03-05 | Davies Scott M | +6,824 | $128.24 | $875,110 |
| 2026-03-05 | Davies Scott M | +5,849 | $128.24 | $750,076 |
| 2026-03-05 | Dhingra Ankur | +10,918 | $128.24 | $1,400,124 |
| 2026-03-05 | Dhingra Ankur | +10,918 | $128.24 | $1,400,124 |
| 2026-03-05 | Dhingra Ankur | +9,358 | $128.24 | $1,200,070 |
| 2026-03-05 | Ericksen Scott D | +1,609 | $128.24 | $206,338 |
| 2026-03-05 | Ericksen Scott D | +1,609 | $128.24 | $206,338 |
| 2026-03-05 | Ericksen Scott D | +3,217 | $128.24 | $412,548 |
| 2026-03-05 | Leckman Patricia | +7,369 | $128.24 | $945,001 |
| 2026-03-05 | Leckman Patricia | +7,369 | $128.24 | $945,001 |
| 2026-03-05 | Leckman Patricia | +6,317 | $128.24 | $810,092 |
| 2026-03-05 | Pegels Kevin Carl | +7,369 | $128.24 | $945,001 |
| 2026-03-05 | Pegels Kevin Carl | +7,369 | $128.24 | $945,001 |
| 2026-03-05 | Pegels Kevin Carl | +6,317 | $128.24 | $810,092 |
| 2026-03-05 | Thaysen Jacob | +30,022 | $128.24 | $3,850,021 |
| 2026-03-05 | Thaysen Jacob | +30,022 | $128.24 | $3,850,021 |
| 2026-03-05 | Thaysen Jacob | +25,734 | $128.24 | $3,300,128 |
| 2026-03-05 | Wedel Christensen Jakob | +6,551 | $128.24 | $840,100 |
| 2026-03-05 | Wedel Christensen Jakob | +6,551 | $128.24 | $840,100 |
| 2026-03-05 | Wedel Christensen Jakob | +5,615 | $128.24 | $720,068 |
| 2026-02-20 | Davies Scott M | -1,336 | $116.18 | $155,216 |
| 2026-02-18 | Leckman Patricia | -2,370 | $116.18 | $275,347 |
| 2026-02-15 | Barnard Steven | -1,259 | $116.51 | $146,686 |
| 2026-02-15 | Ericksen Scott D | -694 | $116.51 | $80,858 |
| 2026-02-15 | Pegels Kevin Carl | -1,164 | $116.51 | $135,618 |
| 2026-02-15 | Davies Scott M | -1,037 | $116.51 | $120,821 |
| 2026-02-15 | Thaysen Jacob | -6,544 | $116.51 | $762,441 |
| 2026-02-15 | Wedel Christensen Jakob | -578 | $116.51 | $67,343 |
| 2026-02-15 | Leckman Patricia | -1,304 | $116.51 | $151,929 |
| 2026-02-12 | Barnard Steven | -1,421 | - | - |
| 2026-02-12 | Barnard Steven | -1,256 | - | - |
| 2026-02-12 | Barnard Steven | -1,014 | $114.44 | $116,042 |
| 2026-02-12 | Barnard Steven | +1,421 | - | - |
| 2026-02-12 | Barnard Steven | +1,256 | - | - |
| 2026-02-12 | Thaysen Jacob | -13,264 | - | - |
| 2026-02-12 | Thaysen Jacob | -5,470 | $114.44 | $625,987 |
| 2026-02-12 | Thaysen Jacob | +13,264 | - | - |
| 2026-02-12 | Pegels Kevin Carl | -2,283 | - | - |
| 2026-02-12 | Pegels Kevin Carl | -874 | $114.44 | $100,021 |
| 2026-02-12 | Pegels Kevin Carl | +2,283 | - | - |
| 2026-02-12 | Davies Scott M | -1,370 | - | - |
| 2026-02-12 | Davies Scott M | -550 | $114.44 | $62,942 |
| 2026-02-12 | Davies Scott M | +1,370 | - | - |
| 2026-02-12 | Leckman Patricia | -1,028 | - | - |
| 2026-02-12 | Leckman Patricia | -424 | $114.44 | $48,523 |
| 2026-02-12 | Leckman Patricia | +1,028 | - | - |
| 2026-02-12 | Ericksen Scott D | -743 | - | - |
| 2026-02-12 | Ericksen Scott D | -306 | $114.44 | $35,019 |
| 2026-02-12 | Ericksen Scott D | +743 | - | - |
| 2026-02-09 | Gottlieb Scott | +200 | $117.81 | $23,562 |
| 2025-12-31 | Ullem Scott B. | +212 | $117.6298 | $24,938 |
| 2025-12-12 | Davies Scott M | -323 | $136.09 | $43,957 |
| 2025-12-08 | Wedel Christensen Jakob | -549 | $129.27 | $70,969 |
| 2025-12-05 | Wedel Christensen Jakob | -307 | $128.96 | $39,591 |
| 2025-11-12 | Davies Scott M | -323 | $122.79 | $39,661 |
| 2025-11-05 | Pegels Kevin Carl | -599 | $122.44 | $73,342 |
| 2025-11-05 | Davies Scott M | -398 | $122.44 | $48,731 |
| 2025-11-05 | Ericksen Scott D | -206 | $122.44 | $25,223 |
| 2025-11-05 | Leckman Patricia | -296 | $122.44 | $36,242 |
| 2025-11-05 | Barnard Steven | -515 | $122.44 | $63,057 |
| 2025-11-03 | Gottlieb Scott | +500 | $122.13 | $61,065 |
| 2025-10-05 | Thaysen Jacob | -1,301 | $101.02 | $131,427 |